MED11

MED11 is an essential subunit of the Mediator complex head module that functions as a critical bridge between Mediator and the general transcription machinery during RNA polymerase II transcription initiation. MED11 forms a conserved four-helix bundle heterodimer with Med22, whose C-terminal extensions bind the central head subunit Med17; a highly conserved surface patch on this bundle directly contacts the TFIIH subunit Rad3, and this interaction is required for recruitment of both TFIIH and TFIIE into the preinitiation complex, enabling Pol II CTD serine 5 phosphorylation genome-wide (PMID:18691966, PMID:21498544, PMID:23123849). A homozygous truncating variant (p.Arg109Ter) in MED11, which disrupts its C-terminal Mediator-binding domain, causes lethal neurodegeneration with microcephaly, a phenotype recapitulated by zebrafish med11 knockout (PMID:36001086). MED11 is also required for HIV-1 transcription at a post-integration step, consistent with its general role in Pol II-dependent transcription initiation (PMID:25100719).

1. 1998 High

   Establishing MED11 as a genuine Mediator subunit resolved whether this polypeptide was an integral component of the Pol II holoenzyme or a contaminant.

   Evidence Copurification and reciprocal co-immunoprecipitation with RNA Pol II holoenzyme from yeast

   PMID:9812975

   Open questions at the time

   • Subunit position within Mediator architecture unknown
   • No functional role assigned beyond complex membership
2. 1999 Medium

   Demonstration that med11 mutation selectively impairs MFalpha1 transcription established that Med11 has activator-specific functions and placed it within the Rgr1 subcomplex.

   Evidence Northern analysis comparing mRNA profiles between wild-type and med11 mutant yeast

   PMID:9891034

   Open questions at the time

   • Molecular basis for activator specificity uncharacterized
   • No direct interaction partners identified
   • Later work reassigned Med11 to the head module rather than Rgr1 subcomplex
3. 2003 Medium

   Identification of mammalian MED11 as a Mediator subunit with direct pairwise binding to other subunits confirmed evolutionary conservation and opened the system to human studies.

   Evidence Tandem mass spectrometry of purified mammalian Mediator fractions and direct biochemical binding assays

   PMID:12584197

   Open questions at the time

   • Identity of direct mammalian binding partners within Mediator not fully mapped
   • Functional relevance of mammalian MED11 not yet tested
4. 2008 High

   Discovery that Med11 directly contacts the TFIIH subunit Rad3 and is required for TFIIH/TFIIE recruitment and CTD Ser5 phosphorylation answered how Mediator mechanistically links to the general transcription machinery.

   Evidence In vivo interaction studies, genome-wide ChIP occupancy analysis, and genetic mutant analysis in yeast

   PMID:18691966

   Open questions at the time

   • Structural basis of the Med11–Rad3 interface unresolved
   • Whether the same contact operates in metazoans not tested
5. 2011 High

   Structural and functional characterization of the Med11–Med22 four-helix bundle heterodimer, including identification of a conserved surface patch essential for PIC assembly, defined the minimal architectural unit through which Med11 operates.

   Evidence Structure-function analysis with mutagenesis, in vitro PIC formation, and in vivo transcription assays

   PMID:21498544

   Open questions at the time

   • Atomic-resolution structure of Med11–Med22 bundle not yet determined at this point
   • Whether the conserved patch directly contacts Rad3 or acts indirectly not distinguished
6. 2012 High

   The crystal structure of the S. pombe Mediator head module at 3.4 Å placed Med11 within the neck/helical spine, revealing how it contributes to the flexible architecture that interfaces with Pol II and its CTD.

   Evidence X-ray crystallography of the head module; structural comparison with S. cerevisiae

   PMID:23123849

   Open questions at the time

   • Full human Mediator head module structure with Med11 not available
   • Conformational dynamics of the Med11-containing neck during PIC assembly unresolved
7. 2014 Medium

   Demonstrating that MED11 knockdown impairs HIV-1 transcription at the post-integration step extended MED11's role to a specific human pathological context dependent on Pol II transcription initiation.

   Evidence siRNA knockdown in human cells with RT-PCR quantification and viral replication assays

   PMID:25100719

   Open questions at the time

   • Whether the effect is direct or indirect through global Mediator disruption not distinguished
   • No rescue experiment reported
8. 2022 Medium

   Linking a homozygous MED11 truncating variant to lethal neurodegeneration in humans, with phenocopy in zebrafish knockout, established MED11 as a disease gene and showed that its C-terminal domain is critical for Mediator subunit interactions in vivo.

   Evidence Patient fibroblast biochemistry (Western blot, RT-PCR), CRISPR/Cas9 zebrafish med11 KO, computational structural modeling

   PMID:36001086

   Open questions at the time

   • Why neural tissue is preferentially vulnerable is unexplained
   • Specific Mediator subunit interactions disrupted by the truncation not biochemically mapped
   • No patient-derived neuronal cell models tested

• High-resolution structural detail of how Med11 engages TFIIH in the human PIC, the basis for tissue-specific vulnerability in MED11-associated neurodegeneration, and whether Med11 participates in gene-selective regulatory circuits beyond HIV-1 transcription remain unresolved.
• No cryo-EM or crystal structure of Med11–TFIIH interface in the human PIC
• Mechanism of neural-selective pathology unknown
• Gene-selective versus global transcriptional role of Med11 in mammalian cells not systematically profiled